Silihan lan utang jangka dawa perusahaan: Jyong Biotech Corp (MENS)

Jyong Biotech Ltd is based on Taiwanese research centers, utilizing contract manufacturing for plant-based products. The size of the firm's long-term borrowings demonstrates a financial burden, where 0.00 reflects the latest value of the metric. The company holds unique patents in the men's health segment. However, a critical imbalance toward a few early developments creates serious regulatory risks for MENS.

For Jyong Biotech Ltd (MENS), the expansion of Asian pharmacy chains requires significant capital, which is reflected in the dynamics of the company's long-term debt levels. This metric aggregates all obligations with a maturity exceeding one year, allowing investors to assess the long-term credit load and solvency risks during business scaling, where rising borrowings may indicate either investments in growth or financial instability.